Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Strategies for Advanced Non-Small Cell Lung Cancer.
Jani CT, Desai A, Lopes GL Jr. Jani CT, et al. Among authors: lopes gl jr. JAMA Netw Open. 2025 Jun 2;8(6):e2514535. doi: 10.1001/jamanetworkopen.2025.14535. JAMA Netw Open. 2025. PMID: 40526393 Free article. No abstract available.
Topical formulation of Oseltamivir promotes clinical improvement and reduction of parasite load in BALB/c mice infected with Leishmaniamajor.
Passos VHAA, Leal PPMS, Lima Neta PP, Melo ECS, Silva VS, Lopes GLN, Nascimento MOD, Coelho ES, Guerra SPL, Lustosa AKMF, Rodrigues VCC, Carvalho ALM, Carvalho FAA, Alves MMM. Passos VHAA, et al. Among authors: lopes gln. Exp Parasitol. 2025 Jul;274:108966. doi: 10.1016/j.exppara.2025.108966. Epub 2025 May 27. Exp Parasitol. 2025. PMID: 40441373
Homologous recombination deficiency test validation in patients with high-grade advanced ovarian cancer.
Nogueira Rodrigues A, Souto AKBA, de Andrade DAP, Gomes LM, Koide SS, E Silva RG, de Souza BB, Massaro JD, de Melo AC, Borges AM, Giro C, de Andrade CAV, da Costa CM, Gimenes DL, de Mello ECB, de Oliveira FC, Lima FMT, Lopes GL, Bretas GO, Jacob GG, Silva HLDC, Notaro JF, Alves LL, Moitinho MV, da Silva MC, Abramoff R, Rauber TADC, Dienstmann R, Koyama FC. Nogueira Rodrigues A, et al. Among authors: lopes gl. Front Mol Biosci. 2025 Feb 11;12:1524594. doi: 10.3389/fmolb.2025.1524594. eCollection 2025. Front Mol Biosci. 2025. PMID: 40007558 Free PMC article.
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al-Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL. Heath E, et al. Among authors: lopes gl. Cancer Res Commun. 2024 Oct 1;4(10):2598-2609. doi: 10.1158/2767-9764.CRC-24-0321. Cancer Res Commun. 2024. PMID: 39172022 Free PMC article.
Chemical Characterization, Leishmanicidal Activity and In Vitro Cytotoxicity of the Essential Oil Extracted from Pectis brevipedunculata (Gardner) Sch.Bip. and Its Incorporation into Microemulsion Systems.
Lopes ACCB, do Nascimento JR, Camara MBP, Lima ADS, Lopes GLN, do Nascimento MO, Xavier JKAM, de Jesus CM, Mendonça CJS, Carvalho ALM, Silva LA, da Rocha CQ. Lopes ACCB, et al. Among authors: lopes gln. Pharmaceutics. 2024 Jan 9;16(1):87. doi: 10.3390/pharmaceutics16010087. Pharmaceutics. 2024. PMID: 38258098 Free PMC article.
Correction to: Innovative Microemulsion Loaded with Unusual Dimeric Flavonoids from Fridericia platyphylla (Cham.) L.G. Lohmann Roots.
do Nascimento JR, de Matos Monteiro Lira BS, do Nascimento MO, Lopes GLN, Ferreira GM, de Souza Nunes GC, Gonçalves RS, Carvalho ALM, Vilegas W, da Rocha CQ. do Nascimento JR, et al. Among authors: lopes gln. AAPS PharmSciTech. 2023 Nov 14;24(8):227. doi: 10.1208/s12249-023-02688-4. AAPS PharmSciTech. 2023. PMID: 37964166 No abstract available.
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, Choi H, Deeken J, Desai A, Edwin N, Feldman LE, Flora DB, Friese CR, Galsky MD, Gonzalez CJ, Grivas P, Gupta S, Haynam M, Heilman H, Hershman DL, Hwang C, Jani C, Jhawar SR, Joshi M, Kaklamani V, Klein EJ, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Labaki C, Lammers PE, Lathrop KI, Lewis MA, Li X, Lopes GL, Lyman GH, Makower DF, Mansoor AH, Markham MJ, Mashru SH, McKay RR, Messing I, Mico V, Nadkarni R, Namburi S, Nguyen RH, Nonato TK, O'Connor TL, Panagiotou OA, Park K, Patel JM, Patel KG, Peppercorn J, Polimera H, Puc M, Rao YJ, Razavi P, Reid SA, Riess JW, Rivera DR, Robson M, Rose SJ, Russ AD, Schapira L, Shah PK, Shanahan MK, Shapiro LC, Smits M, Stover DG, Streckfuss M, Tachiki L, Thompson MA, Tolaney SM, Weissmann LB, Wilson G, Wotman MT, Wulff-Burchfield EM, Mishra S, French B, Warner JL, Lustberg MB, Accordino MK, Shah DP; COVID-19 and Cancer Consortium. Nagaraj G, et al. Among authors: lopes gl. Elife. 2023 Oct 17;12:e82618. doi: 10.7554/eLife.82618. Elife. 2023. PMID: 37846664 Free PMC article.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP; COVID-19 and Cancer Consortium. Gulati S, et al. JAMA Oncol. 2023 Oct 1;9(10):1390-1400. doi: 10.1001/jamaoncol.2023.2934. JAMA Oncol. 2023. PMID: 37589970 Free PMC article.
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden.
Florou V, Floudas CS, Maoz A, Naqash AR, Norton C, Tan AC, Sokol ES, Frampton G, Soares HP, Puri S, Swami U, Wilky B, Hosein P, Trent J, Lopes GL, Park W, Garrido-Laguna I. Florou V, et al. Among authors: lopes gl. J Immunother Cancer. 2023 Aug;11(8):e007440. doi: 10.1136/jitc-2023-007440. J Immunother Cancer. 2023. PMID: 37586768 Free PMC article.
45 results